Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A, Imai Y, Tago H, Asada T, Shigeta M, Iwamoto T, Takita M, Arimoto I, Koma H, Takase T, Ohbayashi T.
Dement Geriatr Cogn Disord. 2009;27(3):232-9. Epub 2009 Feb 25.PMID: 19246907 [PubMed - indexed for MEDLINE]Related articles